Method for detecting target nucleic acids using plasmonic immunomagnetic nanoparticles
Plasmonic immunomagnetic nanoparticles facilitate rapid and cost-effective nucleic acid detection by overcoming the limitations of traditional iPCR and photonic PCR, providing a suitable solution for point-of-care diagnostics.
Patent Information
- Application Number
- JP2024021037
- Authority / Receiving Office
- JP · JP
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2023-05-09
- Filing Date
- 2024-02-15
- Publication Date
- 2024-11-21
- Estimated Expiration
- 2044-02-15
AI Technical Summary
Traditional iPCR methods are limited by the use of sophisticated and expensive Peltier-based thermal block modules, making them unsuitable for point-of-care (POC) diagnosis, while photonic PCR faces challenges hindering its widespread application.
A method utilizing plasmonic immunomagnetic nanoparticles (PIMN) for target nucleic acid detection, involving binding capture and detection antibodies, amplifying with a nucleic acid polymerase, and detecting using photothermal cyclic amplification, enabling rapid and cost-effective detection.
The method enables quick and economical detection of target nucleic acids, suitable for various fields including molecular biology and medicine, with enhanced sensitivity and selectivity, and can be adapted for point-of-care diagnostics.
Smart Images

Figure 2024163007000001_ABST
Abstract
Description
[Technical field]
[0001] The present invention relates to a method for detecting a target nucleic acid using plasmonic immunomagnetic nanoparticles. This invention was completed with support from the Ministry of Science, ICT and Technology of the Republic of Korea under assignment number 2022R1F1A1070162 (1711171631). [Background technology]
[0002] iPCR (Immuno-polymerase chain reaction) is an immunoassay method for ultrasensitive quantification of proteins using the specificity of antigen-antibody interactions and the amplification ability of PCR. In general, iPCR can increase sensitivity by several thousand to several hundred million times compared to ELISA (enzyme-linked immunosorbent assay) due to the exponential amplification ability of PCR. However, the conventional qPCR thermal cycler used in iPCR is an elaborate but expensive, time- and energy-consuming Peltier-based thermal block module, which has limited applicability to point-of-care (POC) diagnostics.
[0003] Recently, photonic PCR using the photothermal effect of plasmonic nanomaterials has attracted attention because of its fast and high photothermal conversion capability. However, photonic PCR still has some problems that limit its widespread application.
[0004] Therefore, in order to solve the above-mentioned problems, the present inventors developed a plasmonic photothermal quantitative iPCR (PPT-qiPCR) using multifunctional plasmonic immunomagnetic nanoparticles (PIMN). Summary of the Invention [Problem to be solved by the invention]
[0005] In one embodiment, the method comprises the steps of: (a) coupling a capture antibody to plasmonic immunomagnetic nanoparticles (PIMN); (b) binding the detection antibody to a streptavidin-nucleic acid complex; (c) mixing the capture antibody-bound nanoparticles and the detection antibody-bound complex; and (d) separating the mixed nanoparticles and complexes; (e) amplifying the target nucleic acid using the complex, the primer and the nucleic acid polymerizing enzyme; and (f) a step of detecting the target nucleic acid.
[0006] Another aspect is to provide multifunctional plasmonic immunomagnetic nanoparticles, including iron oxide nanoclusters, gold nanoshells and antibodies. [Means for solving the problem]
[0007] One embodiment is a method for detecting a magnetic particle using a capture antibody and a plasmonic immunomagnetic nanoparticle (PIMN). ic immunomagnetic nanoparticles; (b) binding the detection antibody to a streptavidin-nucleic acid complex; (c) mixing the capture antibody-bound nanoparticles and the detection antibody-bound complex; and (d) separating the mixed nanoparticles and complexes; (e) amplifying the target nucleic acid using the complex, the primer and the nucleic acid polymerizing enzyme; and (f) detecting the target nucleic acid.
[0008] The term "streptavidin" refers to a 52 kDa protein purified from Streptomyces avidinii.
[0009] The term "primer" refers to a short gene sequence that serves as the starting point for the production of another polymer strand complementary to a template during DNA synthesis.
[0010] In one embodiment, the plasmonic immunomagnetic nanoparticles in step (a) may have magnetic and photothermal properties.
[0011] The term "magnetism" means that a magnet exerts some effect on surrounding objects.
[0012] The term "photothermal property" refers to the property of being able to specifically stimulate a desired site using light energy.
[0013] The term "plasmonic immunomagnetic nanoparticles (PIMN)" refers to iron oxide nanoclusters that have magnetic and photothermal properties. The term refers to nanoparticles composed of nanoparticles composed of nanoclusters, gold nanoshells and antibodies.
[0014] In one embodiment, in step (a), the capture antibody may be covalently bound to the surface of the nanoparticle.
[0015] The term "capture antibody" refers to an antibody that can specifically bind to one or more target proteins (antigens).
[0016] The term "covalent bond" refers to a bond that is formed when atoms share electrons in a chemical bond.
[0017] In one embodiment, the detection antibody in step (b) may be biotinylated.
[0018] The term "detection antibody" refers to an antibody that can bind to the target protein (antigen) captured by the capture antibody.
[0019] In one embodiment, the detection antibody is biotinylated to increase detection efficiency. It could be something.
[0020] In one embodiment, in step (c), the nanoparticles and the complex may be mixed in a sandwich structure.
[0021] In one embodiment, the nanoparticles and the complexes in step (d) may be magnetically separated.
[0022] In one embodiment, the polymerase in step (e) may be one or more selected from the group consisting of Taq polymerase, VENT polymerase, DEEPVENT polymerase, PWO polymerase, and Pfu polymerase.
[0023] In one embodiment, the amplification in step (e) may be performed through photothermal cycling amplification.
[0024] In one embodiment, the detecting in step (f) may be performed using one or more selected from the group consisting of colorimetric analysis, fluorescent analysis, Raman analysis, and gel electrophoresis.
[0025] The term "colorimetric analysis" refers to testing or quantifying the concentration of a chemical compound or solution by measuring the absorbance of specific wavelengths of light using a color reagent or the like.
[0026] The term "fluorescence analysis" refers to a chemical analysis method that uses the fluorescence of a substance, and refers to converting a non-fluorescent sample into a fluorescent substance through a chemical reaction and analyzing the fluorescence.
[0027] The term "Raman analysis" refers to the use of light to generate (excite) molecular motion and to analyze such interactions to chemically analyze a sample.
[0028] The term "gel electrophoresis" refers to the separation of DNA, RNA, proteins, etc. by passing an electric current through a gel matrix.
[0029] Another embodiment provides multifunctional plasmonic immunomagnetic nanoparticles comprising iron oxide nanoclusters, gold nanoshells and antibodies.
[0030] The "iron oxide nanoclusters", "gold nanoshells", "antibodies", "plasmonic immunomagnetic nanoparticles", etc. may be within the scope described above.
[0031] In one embodiment, the iron oxide nanoclusters may be magnetic.
[0032] In one embodiment, the gold nanoshells may have photothermal properties. Effect of the Invention
[0033] The method for detecting target nucleic acids using plasmonic immunomagnetic nanoparticles according to one embodiment enables the detection of target substances quickly and easily at low cost, and can be used in a variety of fields such as molecular biology, medicine, and biological classification. [Brief description of the drawings]
[0034] [Figure 1] FIG. 1 is a schematic diagram of the workflow of plasmonic photothermal quantitative immuno-PCR using plasmonic immunomagnetic nanoparticles for IL-6 detection. [Figure 2a] 2a to 2f are diagrams showing the results of characterizing PIMN. Specifically, Fig. 2a shows the results of observing the high-angle annular dark-field and elemental mapping images of PMN (Au: red, Fe: green) and magnetic nanocluster cores by transmission electron microscopy (TEM). [Figure 2b] 2b to 2d show the hydrodynamic diameter distribution (b), zeta potential (c), and UV-Vis spectrum (d) of PMNs at different stages of surface modification. [Figure 2c] Continued from Figure 2b. [Figure 2d] Continued from Figure 2c. [Figure 2e] Figure 2e shows the results of confirming the temperature profile of one photothermal cycle between 72 °C and 95 °C with various optical densities of PIMN. [Figure 2f] FIG. 2f shows the results of checking the calculated heating and cooling rates. [Figure 3a] Figures 3a to 3d show scanning electron microscopy images of iron oxide (a), (b) Fe3O4@Au seeds, (c) Fe3O4@Au, and (d) Fe3O4@Au-MPA (scale bar: 500 nm). [Figure 3b] Continued from Figure 3a. [Figure 3c] Continued from Figure 3b. [Figure 3d] Continued from Figure 3c. [Figure 4] FIG. 4 shows the EDX pattern of Fe3O4@Au (A) and the XRD patterns of Fe3O4 and Fe3O4@Au (B). [Diagram 5] FIG. 5 shows a diagram of a home-build apparatus for PPT-qiPCR. [Figure 6] FIG. 6 shows the results of checking the temperature profile of a solution without PIMM. [Figure 7] FIG. 7 shows the results of checking the thermal stability before and after 35 photothermal cycles. [Figure 8] Figure 8 shows the amplification curves of real-time PPT-qiPCR using target IL-6 (1,000 pg / ml), different amounts of SG dye (A), 3% agarose gel electrophoresis analysis (B), and fluorescence spectrum (SG7x). [Figure 9] FIG. 9 shows the results of confirming the amplification curves of real-time PPT-qiPCR obtained from IL-6 (1,000 pg / ml) and PIMN at different concentrations. [Figure 10a] Figures 10a to 10g show the results of confirming the characteristics of PPT-qiPCR using PIMN. Specifically, Figure 10a is a schematic diagram of PPT-qiPCR using real-time and end-point fluorescence dual-readout. [Figure 10b] FIG. 10b shows the results of identifying a typical photothermal amplification temperature profile. [Figure 10c] Figure 10c shows the results of confirming the real-time amplification curves of PPT-qiPCR at different concentrations of IL-6 (1000, 100, 50, 10, 5, and 1 pg mL-1). [Figure 10d] FIG. 10d shows the results of confirming the Cq value of the real-time amplification curve. [Figure 10e]Figure 10e shows the results of confirming the endpoint fluorescence curve of PPT-qiPCR for the same sample as in Figure 10c (red and black plots are the endpoint fluorescence signals before and after magnetic separation, respectively). [Figure 10f] Figure 10f shows the fluorescence and gel electrophoresis images of PPT-qiPCR (lanes 1-9: 0, 0.25, 0.05, 0.5, 1, 10, 100, 500, 1000 pg mL-1). [Figure 10g] FIG. 10g shows the results of a selectivity test of PPT-qiPCR [PBS buffer, tumor necrosis factor-α (TNF-α), hemoglobin (Hb)]. [Figure 11] FIG. 11 shows the fluorescence quenching effect with different concentrations of targets and fixed concentrations of nanoparticles. [Figure 12a] 12a to 12c show the results of colorimetric PPT-qiPCR for IL-6 detection. Specifically, Fig. 12a is a schematic diagram of the workflow of endpoint colorimetric PPT-qiPCR. [Figure 12b] Figure 12b is an image of the results of performing end-point colorimetric PPT-qiPCR. [Figure 12c] FIG. 12c shows the absorbance plot of the endpoint colorimetric PPT-qiPCR solution at 650 nm. [Figure 13] FIG. 13 shows the change in pH of the iPCR buffer by the addition of MES buffer (A) and a comparison of the absorbance measured after 35 thermal cycles depending on the TMB concentration (B). [Figure 14] FIG. 14 is a diagram showing the results of confirming the optimization of the irradiation time. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0035] The present invention will be described in more detail below with reference to examples. However, these examples are merely for illustrative purposes and are not intended to limit the scope of the present invention. EXAMPLES
[0036] 1. Experimental materials and methods
[0037] (1) Experimental materials Ferric chloride hexahydrate (FeCl 3 6H 2 O), 3-aminopropyltrimethoxysilane (APTMS), tetrakis(hydroxymethyl)phosphonium chloride (THPC), hydrogen tetrachloroaurate trihydrate (HAuCl 4 3H 2 O), sodium acetate, trisodium citrate dihydrate, potassium carbonate (K 2 CO 3 ) and bovine serum albumin (BSA) were purchased from Sigma-Aldrich. Formaldehyde (HCHO) was obtained from TCI Company, and 3,3',5,5'-tetramethylbenzidine (TMB) and 3-mercaptopropionic acid (MPA) were purchased from Energy chemical. Purified anti-human IL-6 antibody (clone MQ2-13A5, rat monoclonal), Biotin anti-human IL-6 antibody (clone MQ2-39C3, rat monoclonal), recombinant human IL-6 and purified streptavidin ( Streptavidin was purchased from BioLegend. Forward primer (5'-CATCGTCTGCCTGTCATGGGCTGTTAAT-3': SEQ ID NO:1), reverse primer (5'-TCGCCAGCTTCAGTTCTCTGGCATTT-3': SEQ ID NO:2), and 112-base pair (bp) X-DNA target with a biotin label at the 5' end were purchased from Integrated DNA Technologies (Coralville, IA, USA). Dream Taq DNA polymerase (0.05 U μL -1 ), reaction buffer (MgCl 2 , 4 mM), dNTP mixture (0.4 mM each) and MES buffer (8 μL, BupH TM MES buffered saline packs, 28390, 0.1 M MES, 0.9% sodium chloride, pH 4.7) were purchased from Thermo Fisher Scientific, and SYBR® Green I (excitation at 497 nm and emission at 530 nm) was purchased from Molecular Probes, Inc. Quick-Load® purple low molecular weight DNA ladder, Quick-Load® purple 1 kb DNA ladder, and gel loading dye (purple, 6x) were purchased from New England BioLabs, Inc. The morphology and size distribution of PMNs and other intermediates were examined by transmission electron microscope (TEM, Tecnai 12, Philips) and Field Emission TEM (FE-TEM, JEM-F200, JEOL). UV-Vis absorption spectra were obtained from Cary. The reaction was monitored using a UV-Vis Spectrophotometer (Agilent Technologies, USA).
[0038] (2) Synthesis of magnetic nanoparticles and plasmonic magnetic nanoparticles (PMN)
[0039] First, 0.34 g of FeCl 3 6H 2 O, 0.6 g of sodium acetate and 0.11 g of trisodium citrate dihydrate were dissolved in ethylene glycol (10 mL), the mixture was stirred and sonicated for 2 h, and then sealed in a Teflon-lined stainless-steel autoclave. The autoclave was heated at 200 °C and maintained for 12 h, and the magnetic products were collected by magnetic separation, washed three times with ethanol / deionized water (DIW), and dried at 60 °C before use. For PMN, the same synthesis method was used as previously described [Fast and sensitive immuno-PCR assisted by plasmonic magnetic nanoparticles, Appl Mater Today, 23 (2021)].
[0040] (3)PPT-qiPCR optical device
[0041] Infrared LED (850nm peak wavelength, mounted on metal core PCB, 8.5W rated power, 3.8W radiant flux at 700mA forward current, 12.4V forward voltage, LZ4-40R608, LED Engine, CA, USA), Blue LED (460nm peak wavelength, mounted on metal core PCB, 10W power rating, 3.9W radiant flux at 700mA forward current and 14V forward voltage, LZ4-40B208, LED Engine, CA, USA), IR thermometer (OPTCSTCLT15), blue LED (5mm, 480nm peak wavelength, 3.2V forward voltage, 20mA forward current, 4.1cd, C503B-BCN-V0Z0461, CREE, Inc., NC, USA), FITC emission filter (center wavelength = 475nm, bandwidth = 35nm, MF475-35, Thorlabs, Inc., NJ, USA), spectrophotometer (CCS200, Thorlabs, Inc., NJ, USA) and optical fiber (M0065-51-0034, Thorlabs, Inc., NJ, USA). The PPT-qiPCR optical system was constructed using a LabVIEW program. The power supply, thermal cycling with LEDs, cooling fan, fluorescence measurement, and temperature measurement were controlled by the LabVIEW program.
[0042] (4) Surface carboxylation of PMN (PMN-MPA)
[0043] The synthesis of magnetic nanoparticles and PMNs was carried out as in our previous study (Fast and sensitive immuno-PCR assisted by plasmonic magnetic nanoparticles, Appl Mater Today, 23 (2021)). PMNs (0.25 mL, 1 mg mL -1 in DIW) and 3-mercaptopropionic acid (0.5 μL, MPA), the mixture was sonicated for 30 min and centrifuged at 1,500 g for 8 min, then washed with DIW and finally washed with DIW (1 mg mL -1 ) and redispersed.
[0044] (5) Production of Plasmonic Immunomagnetic Nanoparticles (PIMN)
[0045] The capture antibody was conjugated to PMNs through carbodiimide coupling. Specifically, PMN-MPA (20 μL, 1 mg mL -1 in DIW), N-(3-Dimethylaminopropyl)-N'-ethylcarbodimide hydrochloride (25 μL, 10 mg mL -1 in pH 5.5 MES buffer) and anti-human IL-6 Ab (10 μL, 0.5 mg mL -1 in pH 5.5 MES buffer) for 1 h. The remaining active sites of the nanoparticles were blocked with bovine serum albumin (BSA, 2.0 wt%), and the products were washed with PBS (0.05 wt% Tween-20) to remove excess capture antibody and BSA, resuspended in PBS, and stored at 4 °C.
[0046] (6) PCR tube immunoassay
[0047] The functionalized nanoparticle-based immunoassay was performed as follows: 25 μL IL-6 samples were added to the IL-6 nanoparticles at various concentrations (1000, 500, 100, 10, 1, 0.1, 0.05, 0.025, 0 pg mL -1 ) in PIMN (12.5 μL, 0.2 mg mL -1 , 6OD) and biotin anti-human IL-6 detection antibody (12.5 μL, 0.005 mg mL -1 After incubation for 1 h on a shaker, the samples were washed three times with PBS (0.05 wt% Tween-20) using magnetic separation. The pre-conjugated streptavidin-dsDNA complexes were mixed with streptavidin (2.5 μL, 10 μg mL -1 ) and biotin-dsDNA (9.4 μL, 0.1 μM) at room temperature for 30 min (1:2 ratio). Then, the pre-conjugated streptavidin-dsDNA complex was mixed for another 30 min. The sandwich immune complex formed with the dsDNA template was washed several times with PBS (0.05 wt% Tween-20) to reduce background noise and prevent non-specific interactions. Afterwards, the complex solution was redispersed in 5 μL PBS for further PCR reaction.
[0048] (7) Preparation of PCR mixture for PPT-qiPCR
[0049] The 10 μL reaction mixture for PCR amplification is as follows: PCR buffer (1 μL, 10×), forward primer (0.5 μL, 10 μM), reverse primer (0.5 μL, 10 μM), dNTPs (0.2 μL, 10 μM), DNA polymerase (0.3 μL, 5 U μL), and 10 μl of 10 ... -1 ), SYBR Green I (0.5 μL, 140x in DMSO), PIMN-sandwich (5 μL, 15 OD), nuclease-free water (2 μL ) and mineral oil (10 μL, mixture). PPT-qiPCR was performed in two steps: initial denaturation at 95°C (5 s), 35 photothermal cycling between 95°C (1 s) and 72°C (8 s), and the reaction was monitored by measuring the fluorescence emission signal at 530 nm in real time during annealing / extension at 72°C for 1 s. After amplification, the product solution was mixed with TBE buffer (5 μL, 0.5x) and loading buffer (3 μL, 6x) and subjected to agarose gel (3%) electrophoresis analysis.
[0050] (8)Colorimetric assay
[0051] After PPT-qiPCR, MES buffer (9 μL, 0.1 M, pH 4.7) and TMB (1 μL, final concentration 3 mM) were added to 10 μL of the amplified PCR reaction mixture. The resulting mixture was illuminated for 10 min using Blue-Led.
[0052] 2. Experimental Results
[0053] (1) Multifunctional plasmonic immunomagnetic nanoparticles and plasmonic photothermocycle
[0054] 1) Multifunctional plasmonic immunomagnetic nanoparticles
[0055] Multifunctional plasmonic immunomagnetic nanoparticles (PIMNs) are characterized by the use of Fe 3 O 4 It is composed of nanoclusters, gold nanoshells for plasmonic photothermal conversion, and antibodies for immune reaction (Figure 1). 3 O 4Nanoclusters were prepared via a solvothermal reaction (Figures 2a and 3a). Then, for the growth of the gold shell layer, colloidal gold seeds were immersed in Fe 3 O 4 The gold seeds (Fe 3 O 4 @Au seeds) act as nucleation sites for the formation of a continuous gold shell, resulting in plasmonic magnetic Fe 3 O 4The @Au nanoparticles were displayed on PMN (Figures 2a and 3c). Then, it was confirmed through an electron microscope image that the magnetic core was completely covered with a gold shell (Figure 2a). The crystallinity of the magnetic core and gold shell was confirmed through X-ray powder diffraction (XRD) patterns, and other patterns between the magnetic core and PMN were confirmed to further support the core-shell structure of PMN (Figure 4). In addition, through particle analysis using an electron microscope and dynamic light scattering, it was confirmed that PMN was monodisperse with a uniform size of 108.7 ± 10.4 nm (Figures 2b and 3c). In order to fix the capture antibody to the surface of the nanoparticles, bifunctional 3-mercaptopropionic acid (MPA), which contains sulfhydryl and carboxyl groups, was introduced into the linker between PMN and antibody. PMNs were first modified with MPA through a semi-covalent gold-sulfur (Au-S) bond, after which the antibody was covalently attached to the surface of the nanoparticles by carbodiimide coupling. The modification process was monitored through UV-Vis spectra, zeta potential, and DLS analysis (Figures 2b-d). The surface potential was negative (-39.9 mV) after the modification of PMNs with MPA, indicating the modification of numerous negatively charged carboxyl groups. After the modification of the capture antibody, a significant shift in ζ-potential in the positive direction was observed, confirming the conjugation of the antibody on the PMNs. The successful modification of the antibody on the PMNs was confirmed through an increase in the hydrodynamic radius and LSPR peak broadening of the PMNs, and the strong absorption of PMNs at IR wavelengths allowed the IR light source to be used for photothermal conversion (Figure 2d), suggesting that prolonged light exposure could be used to convert the antibody to heat. It was confirmed that this prevents photobleaching of a fluorescent dye (SYBR(C) green, SG) by ELISA.
[0056] 2) Plasmonic photothermal circulation
[0057] The thermal cycling process, which is the core of iPCR, can be shortened by using the photothermal effect of plasmonic nanoparticles. A homemade IR-LED device was fabricated to study the photothermal conversion of PIMNs (Figure 5). The solution temperature containing IMNs was measured and recorded with a non-contact IR thermometer. As shown in Figure 2e, a representative temperature profile of one photothermal cycle between 72 °C and 95 °C at various optical densities (OD) of PIMNs was confirmed. We also confirmed a linear increase in the heating ramp rate as the PIMN OD increased from 5 to 15. The shortest photothermal cycling time for one cycle was confirmed to be 6 seconds for the 15 OD sample, with a heating rate of 9.32 ± 0.13 °C / s and a cooling rate of 6.45 ± 0.10 °C / s (Figure 2f). Considering that the light energy absorbed by gold nanoparticles has no major energy loss channel other than heat generation, a linear increase in the heating rate can be expected. The temperature accuracy was 72.03 ± 0.35 °C and 94.88 ± 0.21 °C at 95 °C and 72 °C, respectively, and it was confirmed that the heating rate did not increase significantly above 15.0 OD. The above results confirmed that as the nanoparticle concentration increased, the light penetration depth or plasmon resonance changed due to interparticle coupling. In addition, it was confirmed that there was no temperature change without nanoparticles under IR-LED irradiation (Figure 6), and that PIMN exhibited excellent thermal stability after thermal cycling (Figure 7).
[0058] (2) Quantitative immunoassay using real-time and end-point fluorescence dual-readout
[0059] The monitoring function of real-time PCR, which can quantify amplified nucleic acids in real time, is used as the gold standard in molecular diagnostics and is a benchmark technology in fluorescence-based point-of-care diagnostic biosensors, multiplex PCR, and immuno-PCR. Since gold nanoparticles are known to be efficient fluorescent bleaching agents, the concentrations of PIMN and SG dye were optimized to increase the fluorescent signal. Lambda DNA was amplified by PPT-qiPCR using PIMN, and the optimal conditions between PIMN and SG dye concentrations were determined from the amplification curve and gel electrophoresis analysis results. As a result, it was confirmed that the fluorescent signal was proportional to the SG dye concentration (x1 to x7) at a fixed PIMN concentration (7.5 OD), but when the dye concentration was increased to x10 SG dye, the amplification reaction was suppressed (Figure 8). Therefore, the SG dye concentration was fixed at x7. However, the fastest heat release rate was observed when the PIMN concentration was 15.0 OD, but at this concentration, the degree of fluorescence quenching was higher than that at 7.5 OD (FIGS. 9 and 10c), so the nanoparticle concentration was then fixed at 7.5 OD.
[0060] Then, a rapid and sensitive real-time PPT-qiPCR using PIMN was used with various concentrations of human IL-6 under the optimized conditions (Figure 10a). Human IL-6 was detected through a sandwich immunoassay using anti-human IL-6 monoclonal capture antibody and biotinylated anti-human IL-6 monoclonal detection antibody labeled with PIMN. Serial dilutions of human IL-6 were incubated with the capture antibody and detection antibody to construct a sandwich structure, and after washing, the biotinylated detection antibody was assembled with the pre-conjugated streptavidin-DNA template and used as a signal probe in the later PCR reaction. Also, after washing three times, the PCR reaction mixture containing primers and polymerization enzyme was added to the PCR tube, and the ultrafast real-time PCR was performed using an IR-LED device. Real-time PPT-qiPCR was performed. The initial denaturation temperature (95 °C for 5 s) and two-step photothermal cycling between denaturation (1 s, 95 °C) and annealing / extension (8 s, 72 °C) were controlled by a non-contact IR thermometer 35 times. Then, the fluorescence signal of each cycle, which indicates the amplification of the probe DNA, was monitored in real time using a blue LED and a spectrophotometer. The amplification reaction was confirmed to be completed in less than 10 min by the temperature profile (Figure 10b). Compared with commercial thermal cyclers that transfer heat to the reaction solution through PCR tubes with a heating block, the present system with uniformly dispersed nanoparticles confirmed that exceptionally fast thermal cycling is possible because heat can be distributed uniformly directly throughout the reaction mixture. A graph plotting the real-time amplification signal of PPT-qiPCR versus IL-6 concentration shows a typical qPCR amplification curve and was used to determine the quantification cycle (Cq) number (Figure 10c). The Cq values ranged from 5 to 1000 pg mL -1 We confirmed that the assay showed a consistent linear relationship with IL-6 concentrations in the 100 μg / mL titers (Figure 3D->10D), and the achieved sensitivity and dynamic range of real-time PPT-qiPCR were compared with a commercial ELISA kit and are shown in Table 1 below (Table 1).
[0061] [Table 1]
[0062] As described above, after confirming real-time quantitative detection, in situ end-point fluorescence measurement was applied to the PPT-qiPCR system to achieve even higher sensitivity. PIMN can be removed from the solution by simple magnetic separation, so fluorescence quenching can be greatly reduced. After the PPT-qiPCR reaction, PIMN was captured at the bottom of the reaction tube with a magnet, and the in situ end-point fluorescence signal of amplicon was measured at 530 nm and plotted against the IL-6 concentration (Figure 10e). It was confirmed that the measurement of the in situ end-point fluorescence signal including magnetic separation was completed within 15 seconds (Figures 10b and 10e). In addition, as can be seen from the above results, the elimination of fluorescence quenching enabled in situ end-point PPT-qiPCR to achieve a detection range (0.05 to 1000 pg mL-1 ) and improved sensitivity. The quantification plot also showed correct linearity. The fluorescence images before and after magnetic separation shown in Figure 10f and the nanoparticle concentration-dependent fluorescence signal shown in Figure 11 confirmed that the decrease in fluorescence quenching was due to the removal of nanoparticles. [FL]=32208+4269log[C](R 2 = 0.989), the analytical LOD calculated from the correlation equation (FL: fluorescence signal of SG at 530 nm, C: concentration of IL-6) was 21.3 fg mL -1 (3σ Blank ) compared to the LOD of commercial ELISA analysis kits, as shown in Table 1. It was confirmed that the immunomagnetic process using PIMN allows washing after antigen capture, enabling flexible sampling of the analysis solution, shortening washing time, and reducing nonspecific binding and background signals, compared to commercial ELISA kits using microtiter plates. In addition, the selectivity of PPT-qiPCR for nonspecific target proteins was investigated, and as shown in Figure 10g, there was no fluorescent signal distinguishable from the blank and nonspecific targets, demonstrating excellent selectivity. confirmed.
[0063] (3) Colorimetric detection
[0064] Colorimetric biosensors are one of the most suitable platforms for POC diagnostics and resource-limited countries because they are easy to operate and can eliminate expensive and complicated equipment for signal sensing. While maintaining the exponential amplification power of PCR, we extended the system to colorimetric detection using a chromogenic substrate commonly used in ELISA (Figure 12a). To prove that the PPT-qiPCR method is applicable to visually distinguishable colorimetric detection methods, we performed a colorimetric detection of reactive oxygen species (ROS) using a chromogenic substrate commonly used in ELISA (Figure 12b). They took advantage of the photocatalytic properties of the DNA-SG complex to generate singlet oxygen species. In particular, the oxidation of TMB can be induced by singlet oxygen generated in the DNA-SG complex when emitted from underneath a blue LED. The generated singlet oxygen catalyzes the oxidation of TMB, resulting in a color change, and the amount of singlet oxygen is directly related to the amount of amplified target DNA.
[0065] First, the photocatalytic activity of DNA-SG, which generates reactive oxygen species, depending on pH, TMB concentration, and light exposure time was irradiated with a fixed SG concentration of ×7. The absorbance intensity at 650 nm, which indicates TMB oxidation, was monitored, and MES buffer (pH 4.7) was added after PPT-qiPCR to adjust the pH of the solution. As a result, the optimal pH for TMB oxidation using DNA-SG was confirmed to be 5.0, and compared with HRP (horseradish peroxidase) (Figure 13A), the change in absorbance due to the presence or absence of target DNA was confirmed to be the largest at 3 mM TMB concentration (Figure 13B). Since the absorbance did not increase significantly when the light exposure time was 10 minutes or more (Figure 14), further experiments were performed with pH and TMB concentration of 5.0 and 3 mM, respectively, with an exposure time of 10 minutes. After immunomagnetic analysis and PPT-qiPCR using serial dilutions of IL-6, the TMB solution in MES buffer was added to the PCR tube to confirm colorimetric detection. After that, after irradiating with blue LED for 10 min, DNA-SG induced TMB oxidation, and PMNs were magnetically separated for 15 s to confirm the change in hue. Since the degree of photocatalytic activity of DNA-SG is directly related to the amount of amplified amplicon, it was confirmed that the target can be quantified using the change in hue and saturation according to the amount of amplified PCR product. As shown in Figure 12b, the conversion from colorless to blue served as a reliable indicator for the presence or absence of the target, whereas the intensity of the blue color served as evidence of the target concentration. The hue reading was quantified more precisely using a UV-Vis spectrophotometer (Figure 12c). The relationship between absorbance at 650 nm and IL-6 concentration was plotted, and the curve was expressed as [Abs] = 1.46 + 0.67 log [C] (R 2= 0.99) equation (Abs: absorbance of TMB oxidation, C: concentration of IL-6). The colorimetric method was used with a 0.05 pg mL -1 to 1ng mL -1 Wide detection range up to 39.5 fg mL -1 Therefore, the LOD was 0.05 pg mL -1 It was confirmed that even low-level targets could be visually detected. The amplified PPT-qiPCR was further characterized by agarose gel electrophoresis (Figure 10f), which confirmed a clear change in band intensity as the IL-6 concentration was increased.
Claims
1. (a) binding the capture antibody to plasmonic immunomagnetic nanoparticles (PIMN); (b) binding the detection antibody to the streptavidin-nucleic acid complex; (c) mixing the capture antibody-bound nanoparticles and the detection antibody-bound complex; and (d) separating the mixed nanoparticles and complexes; (e) amplifying the target nucleic acid using the complex, the primer and the nucleic acid polymerase; and (f) detecting the target nucleic acid.
2. The method of claim 1 , wherein in step (a), the plasmonic immunomagnetic nanoparticles have magnetic and photothermal properties.
3. The method of claim 1 , wherein in step (a), the capture antibody is covalently bound to the surface of the nanoparticle.
4. The method according to claim 1 , wherein the detection antibody in step (b) is biotinylated.
5. The method of claim 1 , wherein in step (c), the nanoparticles and the complex are mixed in a sandwich structure.
6. 2. The method of claim 1, wherein the polymerase in step (e) is one or more selected from the group consisting of Taq polymerase, VENT polymerase, DEEPVENT polymerase, PWO polymerase, and Pfu polymerase.
7. The method of claim 1 , wherein in step (e), the amplification is performed via photothermal cycling amplification.
8. 2. The method of claim 1, wherein in step (f) the detecting is performed using one or more selected from the group consisting of colorimetric analysis, fluorescent analysis, Raman analysis and gel electrophoresis.
9. Multifunctional plasmonic immunomagnetic nanoparticles, including iron oxide nanoclusters, gold nanoshells and antibodies.
10. The nanoparticles according to claim 9, wherein the iron oxide nanoclusters have magnetism.
11. The nanoparticle of claim 9 , wherein the gold nanoshell has photothermal properties.
Citation Information
Patent Citations
Gold magnetic nano-cluster drug-loaded targeting preparation with core-shell structure as well as preparation method and application of gold magnetic nano-cluster drug-loaded targeting preparation
CN113908273A
Integrated immuno-PCR and nucleic acid analysis in an automated reaction cartridge.
JP2020503857A
Methods and compositions for detecting amplification products
JP2022516442A
Medical and Imaging Nanoclusters
US20130023714A1
Heating mechanism for DNA amplification, extraction or sterilization using photo-thermal nanoparticles
US20140170664A1
